Anti-metastasis effects of ginsenoside Rg3 in B16F10 cells

Journal of Microbiology and Biotechnology

Volumn 25, Issue 12, 2015, Pages 1997-2006

  Lee, Seul Gi ^a   Kang, Young Jin ^b   Nam, Ju Ock ^a  

^a Kyungpook National University   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

B16F10; Cancer; Ginsenoside Rg3; Metastasis; Migration; MMP 13

Indexed keywords

COLLAGENASE 3; GINSENOSIDE RG 3; ANTINEOPLASTIC AGENT; GINSENOSIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B16F10 CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL MEDIATED CYTOTOXICITY; CELL MIGRATION; CELL MOTILITY; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; MELANOMA CELL LINE; METASTATIC MELANOMA; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; WOUND HEALING; ANIMAL; CELL MOTION; DRUG EFFECTS; MELANOMA; METABOLISM; NEOPLASM METASTASIS; SECONDARY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; MATRIX METALLOPROTEINASE 13; MELANOMA; MICE; NEOPLASM METASTASIS;

EID: 84949425337     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1506.06002     Document Type: Article

References (28)

1. Boregowda RK, Olabisi OO, Abushahba W, Jeong BS, Haenssen KK, Chen W, et al. 2014. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion. Cancer Lett. 348: 61-70.
2. Chalkiadaki G, Nikitovic D, Berdiaki A, Katonis P, Karamanos NK, Tzanakakis GN. 2 011. Hep arin p lays a k ey regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration. IUBMB Life 63: 109-119.
3. Chen D, Li Y, Dai X, Zhou X, Tian W, Zhou Y, et al. 2013. 1, 25-Dihydroxyvitamin D3 activates MMP13 gene expression in chondrocytes through p38 MARK pathway. Int. J. Biol. Sci. 9: 649-655.
4. Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv X, Chen F. 2014. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Int. Immunopharmacol. 21: 447-455.
5. Chiang HM, Chan SY, Chu Y, Wen KC. 2015. Fisetin ameliorated photodamage by suppressing the MAP kinase/ MMP pathway and NF-kappaB pathways. J. Agric. Food Chem.
6. Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, et al. 2014. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem. Toxicol. 68: 218-225.
7. Jia D, Yan M, Wang X, Hao X, Liang L, Liu L, et al. 2010. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion. BMC Cancer 10: 364.
8. Jimenez RE, Hartwig W, Antoniu BA, Compton CC, Warshaw AL, Fernandez-Del Castillo C. 2000. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann. Surg. 231: 644-654.
9. Kim JS, Joo EJ, Chun J, Ha YW, Lee JH, Han Y, Kim YS. 2012. Induction of apoptosis by ginsenoside Rk1 in SKMEL- 2-human melanoma. Arch. Pharm. Res. 35: 717-722.
10. Kim JW, Jung SY, Kwon YH, Lee JH, Lee YM, Lee BY, Kwon SM. 2012. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol. Ther. 13: 504-515.
11. Kim SM, Lee SY, Cho JS, Son SM, Choi SS, Yun YP, et al. 2010. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur. J. Pharmacol. 631: 1-9.
12. Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, et al. 2014. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-beta1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Toxicology 322: 23-33.
13. Ko SY, Ko HA, Shieh TM, Chang WC, Chen HI, Chang SS, Lin IH. 2014. Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro. PLoS One 9: e110542.
14. Lecomte J, Masset A, Blacher S, Maertens L, Gothot A, Delgaudine M, et al. 2012. Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor. Neoplasia 14: 943-951.
15. Lee SG, Kim BS, Nam J-O. 2014. Ginsenoside Rg3 induces apoptosis in B16F10 melanoma cells. Kor. J. Life Sci. 24: 1001-1009.
16. Meierjohann S, Hufnagel A, Wende E, Kleinschmidt MA, Wolf K, Friedl P, et al. 2010. MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. Mol. Cancer 9: 201.
17. Ozawa H, Sonoda Y, Kato S, Suzuki E, Matsuoka R, Kanaya T, et al. 2012. Sulfatides inhibit adhesion, migration, and invasion of murine melanoma B16F10 cell line in vitro. Biol. Pharm. Bull. 35: 2054-2058.
18. Pivetta E, Scapolan M, Pecolo M, Wassermann B, Abu- Rumeileh I, Balestreri L, et al. 2011. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res. 13: R105.
19. Song Y, Park HJ, Kang SN, Jang SH, Lee SJ, Ko YG, et al. 2013. Blueberry peel extracts inhibit adipogenesis in 3T3-L1 cells and reduce high-fat diet-induced obesity. PLoS One 8: e69925.
20. Tsai HE, Wu JC, Kung ML, Liu LF, Kuo LH, Kuo HM, et al. 2013. Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]. PLoS One 8: e59345.
21. Wang Z, Jiang C, Chen W. 2014. Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells. 2014: 732516.
22. Westermarck J, Kahari VM. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13: 781-792.
23. Xu TM, Cui MH, Xin Y, Gu LP, Jiang X, Su MM, et al. 2008. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin. Med. J. (Engl.) 121: 1394-1397.
24. Yamada T, Oshima T, Yoshihara K, Tamura S, Kanazawa A, Inagaki D, et al. 2010. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis. Anticancer Res. 30: 2693-2699.
25. Yong HY, Koh MS, Moon A. 2009. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Exp. Opin. Invest. Drugs 18: 1893-1905.
26. Zehavi L, Schayek H, Jacob-Hirsch J, Sidi Y, Leibowitz-Amit R, Avni D. 2015. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma. Mol. Cancer 14: 68.
27. Zhang P, Huang C, Fu C, Tian Y, Hu Y, Wang B, et al. 2015. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b. Oncotarget 6: 9834-9853.
28. Zhao X, Pang L, Qian Y, Wang Q, Li Y, Wu M, et al. 2013. An animal model of buccal mucosa cancer and cervical lymph node metastasis induced by U14 squamous cell carcinoma cells. Exp. Ther. Med. 5: 1083-1088.